ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1315

The Best Cardiovascular Risk Algorithm to Predict the Presence of Carotid Plaque in Psoriatic Arthritis Patients

Natalia Guajardo-Jauregui, Iris Colunga-Pedraza, Jose Azpiri-Lopez, Dionicio Galarza-Delgado, Alejandra Rodriguez-Romero, Diana Flores-Alvarado, Julieta Loya-Acosta, Alejandro Meza-Garza, Jesus Cardenas-de La Garza, Salvador Lugo-Perez and Jessica Castillo-Treviño, Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico

Meeting: ACR Convergence 2021

Keywords: Atherosclerosis, Cardiovascular, Psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes III: Comorbidities, Extra-muskuloskeletal Manifestations, & Related Conditions (1304–1328)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Systemic inflammation in psoriatic arthritis (PsA) patients accelerates the process of atherosclerosis; this increases the risk of presenting a major cardiovascular (CV) event than the general population. The carotid ultrasound (US), a non-invasive diagnostic tool, has the ability of detecting subclinical atherosclerosis, but it is not available to all patients.

The aim of this study was to determine which is the best CV risk (CVR) algorithm to predict the presence of carotid plaque (CP) in PsA patients.

Methods: This was a cross-sectional and observational study. A total of 78 patients aged 40-75 years, who fulfilled the 2006 CASPAR classification criteria for PsA were included. The CVR of each patient was assessed by six different CVR algorithms, including: Framingham Risk Score (FRS)-lipids, FRS-body mass index (FRS-BMI), American College of Cardiology and American Heart Association (ACC/AHA) Risk Algorithm, Systematic Coronary Risk Evaluation (SCORE), QRISK3 and Reynolds Risk Score (RRS). A carotid US was performed in all study subjects to identify the presence of CP. A ROC-curve analysis was done to establish the cut-off points of each algorithm to predict the presence of CP, calculating sensitivity, specificity and area under the curve (AUC) to determine the discriminative capacity. A p-value < 0.05 was considered statistically significant.

Results: Most patients were women (55.1%) with a mean age of 53.46 (±10.86) years. The prevalence of CP was 42.3%. Four of the six CVR algorithms showed the capacity of predicting CP in PsA patients. FRS-lipids showed an AUC 0.653 (0.523-0.783), p=0.025, a cut-off point ≥11.55, a sensitivity of 51.5% and specificity of 68.9%. FRS-BMI showed an AUC 0.661 (0.536-0.786), p=0.019, a cut-off point ≥13.8, sensitivity of 59.4% and specificity of 60.5%. ACC/AHA showed an AUC 0.681 (0.551-0.812), p=0.008, a cut-off point ≥4.8, sensitivity of 63.6% and specificity of 64.4%. QRISK3 showed an AUC 0.680 (0.551-0.810), p=0.008, a cut-off point ≥5.15, sensitivity of 62.5% and specificity of 60.5% (Table 1, Figure 1).

Conclusion: The best CVR algorithm to predict CP in PsA patients was the ACC/AHA risk score. However, there is a need of lower cut-off points to have the capacity of identifying patients classified in the low-moderate risk, according to these algorithms, with subclinical atherosclerosis, who would benefit from an opportune treatment.


Disclosures: N. Guajardo-Jauregui, None; I. Colunga-Pedraza, None; J. Azpiri-Lopez, None; D. Galarza-Delgado, None; A. Rodriguez-Romero, None; D. Flores-Alvarado, None; J. Loya-Acosta, None; A. Meza-Garza, None; J. Cardenas-de La Garza, None; S. Lugo-Perez, None; J. Castillo-Treviño, None.

To cite this abstract in AMA style:

Guajardo-Jauregui N, Colunga-Pedraza I, Azpiri-Lopez J, Galarza-Delgado D, Rodriguez-Romero A, Flores-Alvarado D, Loya-Acosta J, Meza-Garza A, Cardenas-de La Garza J, Lugo-Perez S, Castillo-Treviño J. The Best Cardiovascular Risk Algorithm to Predict the Presence of Carotid Plaque in Psoriatic Arthritis Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-best-cardiovascular-risk-algorithm-to-predict-the-presence-of-carotid-plaque-in-psoriatic-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-best-cardiovascular-risk-algorithm-to-predict-the-presence-of-carotid-plaque-in-psoriatic-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology